- Home
- ORIC vs BOW Comparison
ORIC vs BOW Comparison
Compare ORIC & BOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- BOW
- Stock Information
- Founded
- ORIC 2014
- BOW 2020
- Country
- ORIC United States
- BOW United States
- Employees
- ORIC N/A
- BOW N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- BOW Property-Casualty Insurers
- Sector
- ORIC Health Care
- BOW Finance
- Exchange
- ORIC Nasdaq
- BOW Nasdaq
- Market Cap
- ORIC 1.1B
- BOW 1.1B
- IPO Year
- ORIC 2020
- BOW 2024
- Fundamental
- Price
- ORIC $14.19
- BOW $26.12
- Analyst Decision
- ORIC Strong Buy
- BOW Buy
- Analyst Count
- ORIC 8
- BOW 6
- Target Price
- ORIC $16.57
- BOW $35.67
- AVG Volume (30 Days)
- ORIC 1.6M
- BOW 375.0K
- Earning Date
- ORIC 11-11-2025
- BOW 11-04-2025
- Dividend Yield
- ORIC N/A
- BOW N/A
- EPS Growth
- ORIC N/A
- BOW 41.97
- EPS
- ORIC N/A
- BOW 1.47
- Revenue
- ORIC N/A
- BOW $492,071,000.00
- Revenue This Year
- ORIC N/A
- BOW $19.49
- Revenue Next Year
- ORIC N/A
- BOW $21.79
- P/E Ratio
- ORIC N/A
- BOW $17.64
- Revenue Growth
- ORIC N/A
- BOW 41.21
- 52 Week Low
- ORIC $3.90
- BOW $23.70
- 52 Week High
- ORIC $14.93
- BOW $42.29
- Technical
- Relative Strength Index (RSI)
- ORIC 71.68
- BOW 41.34
- Support Level
- ORIC $13.85
- BOW $23.70
- Resistance Level
- ORIC $14.93
- BOW $27.14
- Average True Range (ATR)
- ORIC 0.81
- BOW 1.04
- MACD
- ORIC 0.35
- BOW 0.10
- Stochastic Oscillator
- ORIC 85.29
- BOW 53.07
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About BOW Bowhead Specialty Holdings Inc. Common Stock
Bowhead Specialty Holdings Inc offers commercial specialty property and casualty insurance products. The company offers underwriting solutions to various businesses across four underwriting divisions, which include Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. A majority of its revenue is generated from the Casualty division which specializes in general liability coverage, which protects a company against liability arising from bodily injury, personal injury or property damage, for risks in the construction, distribution, heavy manufacturing, real estate, public entity and hospitality segments and also considers underwriting risks in a broader range of industries. Geographically, the company operates in the United States.